ArticleNeuro-oncology2024

Expanding therapeutic options for people with NF2-related schwannomatosis: Encouraging results with brigatinib.

Scott R Plotkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.